Age-dependent Deamidation of Lifelong Proteins in the Human Lens
Overview
Authors
Affiliations
Purpose: Deamidation is a common posttranslational modification in human lens crystallins and may be a key factor in the age-related denaturation of such lifelong proteins. The aim of this study was to identify the sites of deamidation in older lenses.
Methods: High-performance liquid chromatography/mass spectrometry of tryptic digests was used to identify sites of deamidation in the major human lens crystallins. Older normal and age-matched cataractous lenses were compared with fetal lenses.
Results: Approximately equal numbers of glutamine and asparagine residues were deamidated in older lenses; however, the extent of deamidation of Asn was three times greater than that of Gln (Asn, 22.6% +/- 3.6%; Gln, 6.6% +/- 1.3%). Individual crystallins differed markedly in their extent of deamidation, and deamidated residues were typically localized within discrete regions of the polypeptides. A large percentage (42%) of the sites of deamidation were characterized by the presence of a basic amino acid one residue removed from the original Gln or Asn. At nine such sites, the extent of Asn deamidation averaged 50% in aged lenses. There were few differences in deamidation between crystallins of aged normal and nuclear cataractous lenses.
Conclusions: Equal numbers of Asn and Gln residues are deamidated in crystallins from aged normal and cataractous lenses. Deamidation of Asn/Gln in lifelong proteins, such as those in the lens, may be governed to a significant degree by base-catalyzed processes.
Enhancing the Thermostability of Alkaline Protease 2709 by Computation-Based Rational Design.
Yuan Y, Zhao G, Lu J, Wang L, Shi Y, Zhang J Molecules. 2025; 30(5).
PMID: 40076384 PMC: 11901772. DOI: 10.3390/molecules30051160.
Guseman A, Gonzalez J, Yang D, Gronenborn A Protein Sci. 2024; 33(8):e5120.
PMID: 39022918 PMC: 11255865. DOI: 10.1002/pro.5120.
Lens Cytoskeleton: An Update on the Etiopathogenesis of Human Cataracts.
Karakosta C, Samiotaki M, Panayotou G, Papaconstantinou D, Moschos M Cureus. 2024; 16(3):e56793.
PMID: 38650819 PMC: 11035009. DOI: 10.7759/cureus.56793.
HLA-DQB1*05 subtypes and not DRB1*10:01 mediates risk in anti-IgLON5 disease.
Yogeshwar S, Muniz-Castrillo S, Sabater L, Peris-Sempere V, Mallajosyula V, Luo G Brain. 2024; 147(7):2579-2592.
PMID: 38425314 PMC: 11224611. DOI: 10.1093/brain/awae048.
Rolland A, Takata T, Donor M, Lampi K, Prell J Structure. 2023; 31(9):1052-1064.e3.
PMID: 37453416 PMC: 10528727. DOI: 10.1016/j.str.2023.06.013.